Rentokil
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Rentokil yesterday claimed just under 11 per cent of bid target BET after picking up a further 7 million shares in the market at 202.5p ahead of tomorrow's closing date. The purchases, made at the same price as the cash alternative offer, take its holding to around 7.5 per cent. It already has acceptances covering 3.4 per cent of BET's shares.
Meanwhile, BET stepped up the war of words, claiming that an academic study showed that the bidder's shares would underperform if it won the takeover battle. An investigation by Kjell Nyborg, assistant professor of finance at the London Business School, showed that Rentokil's share price could fall by 8 per cent "very quickly" after the acquisition, representing a loss of some pounds 440m of shareholder value.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments